Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $38.4M
Liabilities Breakdown FY2021
Total Liabilities: $34.3M
Asset Breakdown
Total Assets: $38.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.7M | 7.0% |
| Accounts Receivable | $4.7M | 12.2% |
| Inventory | $825.0K | 2.1% |
| Property, Plant & Equipment | $317.0K | 0.8% |
| Goodwill | $8.4M | 21.9% |
| Intangible Assets | $2.1M | 5.5% |
| Other Assets | $19.4M | 50.4% |
Liabilities Breakdown
Total Liabilities: $34.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 4.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $32.9M | 96.0% |